According to Aurobindo Pharma 's latest financial reports the company's total liabilities are $1.89 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-03-31 | $1.58 B | 28.82% |
2022-03-31 | $1.23 B | -24.08% |
2021-03-31 | $1.62 B | 1.15% |
2020-03-31 | $1.60 B | -11.28% |
2019-03-31 | $1.80 B | 25.06% |
2018-03-31 | $1.44 B | 36.33% |
2017-03-31 | $1.06 B | -22.63% |
2016-03-31 | $1.37 B | 15.39% |
2015-03-31 | $1.18 B | 24.48% |
2014-03-31 | $0.95 B | 11.31% |
2013-03-31 | $0.85 B | 12.24% |
2012-03-31 | $0.76 B | -0.26% |
2011-03-31 | $0.76 B | 16.06% |
2010-03-31 | $0.66 B | 12.44% |
2009-03-31 | $0.58 B | -6.58% |
2008-03-31 | $0.62 B | 3.7% |
2007-03-31 | $0.60 B | 43.82% |
2006-03-31 | $0.42 B | 29.86% |
2005-03-31 | $0.32 B | 23.27% |
2004-03-31 | $0.26 B |